Free Trial

Alector (ALEC) Stock Forecast & Price Target

Alector logo
$2.54 +0.03 (+1.20%)
(As of 11:33 AM ET)

Alector - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
0
Buy
5

Based on 6 Wall Street analysts who have issued ratings for Alector in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a sell rating, and 5 have given a buy rating for ALEC.

Consensus Price Target

$8.40
230.71% Upside
According to the 6 analysts' twelve-month price targets for Alector, the average price target is $8.40. The highest price target for ALEC is $15.00, while the lowest price target for ALEC is $3.00. The average price target represents a forecasted upside of 230.71% from the current price of $2.54.
Get the Latest News and Ratings for ALEC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alector and its competitors.

Sign Up

ALEC Analyst Ratings Over Time

TypeCurrent Forecast
12/4/23 to 12/3/24
1 Month Ago
11/4/23 to 11/3/24
3 Months Ago
9/5/23 to 9/4/24
1 Year Ago
12/4/22 to 12/4/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$8.40$17.75$14.67$13.70
Forecasted Upside230.71% Upside253.59% Upside217.46% Upside143.77% Upside
Consensus Rating
Moderate Buy
Buy
Moderate Buy
Hold

ALEC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALEC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alector Stock vs. The Competition

TypeAlectorMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside234.66% Upside25,909.61% Upside6.71% Upside
News Sentiment Rating
Neutral News

See Recent ALEC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/29/2024HC Wainwright
2 of 5 stars
 Lower TargetBuy$35.00 ➝ $7.00+175.05%
11/26/2024BTIG Research
2 of 5 stars
 Lower TargetBuy ➝ Buy$16.00 ➝ $5.00+92.31%
11/26/2024Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingOverweight
11/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$10.00 ➝ $3.00-24.24%
12/14/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$8.00 ➝ $15.00+117.39%
12/12/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$12.00+92.62%
11/17/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$10.00 ➝ $9.00+113.78%
9/25/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$4.00-41.86%
5/5/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$14.00 ➝ $12.00+78.57%
3/1/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$17.00 ➝ $12.00+39.70%
1/6/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$24.00 ➝ $12.00+47.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:58 AM ET.


ALEC Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Alector is $8.40, with a high forecast of $15.00 and a low forecast of $3.00.

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alector in the last twelve months. There is currently 1 sell rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALEC shares.

According to analysts, Alector's stock has a predicted upside of 230.71% based on their 12-month stock forecasts.

Over the previous 90 days, Alector's stock had 1 downgrade by analysts.

Alector has been rated by research analysts at BTIG Research, Cantor Fitzgerald, HC Wainwright, and Morgan Stanley in the past 90 days.

Analysts like Alector less than other "medical" companies. The consensus rating score for Alector is 2.67 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ALEC compares to other companies.


This page (NASDAQ:ALEC) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners